Subependymal giant cell astrocytoma historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:
*Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".<ref name="OuyangZhang2014">{{cite journal|last1=Ouyang|first1=Taohui|last2=Zhang|first2=Na|last3=Benjamin|first3=Thomas|last4=Wang|first4=Long|last5=Jiao|first5=Jiantong|last6=Zhao|first6=Yiqing|last7=Chen|first7=Jian|title=Subependymal giant cell astrocytoma: current concepts, management, and future directions|journal=Child's Nervous System|volume=30|issue=4|year=2014|pages=561–570|issn=0256-7040|doi=10.1007/s00381-014-2383-x}}</ref>
*Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".<ref name="OuyangZhang2014">{{cite journal|last1=Ouyang|first1=Taohui|last2=Zhang|first2=Na|last3=Benjamin|first3=Thomas|last4=Wang|first4=Long|last5=Jiao|first5=Jiantong|last6=Zhao|first6=Yiqing|last7=Chen|first7=Jian|title=Subependymal giant cell astrocytoma: current concepts, management, and future directions|journal=Child's Nervous System|volume=30|issue=4|year=2014|pages=561–570|issn=0256-7040|doi=10.1007/s00381-014-2383-x}}</ref>
*Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for [[neurofilament]], [[GFAP]], [[Substance P|substance P]], and [[Neuron-Specific Enolase (NSE)|neuron-specific enolase]].
*Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for [[neurofilament]], [[GFAP]], [[Substance P|substance P]], and [[Neuron-Specific Enolase (NSE)|neuron-specific enolase]].
*The association between subependymal nodule transformating into a subependymal giant cell astrocytoma was first described by Nabbout.
*The transformation of a subependymal nodule into a subependymal giant cell astrocytoma was first described by Nabbout.


==References==
==References==

Revision as of 19:54, 20 November 2015

Subependymal giant cell astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subependymal Giant Cell Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subependymal giant cell astrocytoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subependymal giant cell astrocytoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subependymal giant cell astrocytoma historical perspective

CDC on Subependymal giant cell astrocytoma historical perspective

Subependymal giant cell astrocytoma historical perspective in the news

Blogs on Subependymal giant cell astrocytoma historical perspective

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Subependymal giant cell astrocytoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]

Historical Perspective

  • Russell et al was the first scientist to coin the term "subependymal giant cell astrocytoma".[1]
  • Anna et al. was the first to identify that subependymal giant cell astrocytoma demonstrated immunoreactivity for neurofilament, GFAP, substance P, and neuron-specific enolase.
  • The transformation of a subependymal nodule into a subependymal giant cell astrocytoma was first described by Nabbout.

References

  1. 1.0 1.1 Ouyang, Taohui; Zhang, Na; Benjamin, Thomas; Wang, Long; Jiao, Jiantong; Zhao, Yiqing; Chen, Jian (2014). "Subependymal giant cell astrocytoma: current concepts, management, and future directions". Child's Nervous System. 30 (4): 561–570. doi:10.1007/s00381-014-2383-x. ISSN 0256-7040.


Template:WikiDoc Sources